- citati u SCIndeksu: 0
- citati u CrossRef-u:0
- citati u Google Scholaru:[
 ]
- posete u poslednjih 30 dana:2
- preuzimanja u poslednjih 30 dana:2
|
|
|
2007, vol. 54, br. 3, str. 153-159
|
|
Analiza antiapoptotskog proteina bcl-2 u skvamocelularnom karcinomu usne regije
Analysis of the anti-apoptotic protein bcl-2 in oral squamous cell carcinoma
aUniverzitet u Beogradu, Stomatološki fakultet bUniverzitet u Beogradu, Medicinski fakultet, Institut za biologiju i humanu genetiku
e-adresa: brankapo@verat.ne
Sažetak
Cilj ove studije bio je analiza prisustva antiapoptotskog proteina bcl-2 u skvamocelularnom karcinomu usne regije i procena njegove eventualne uloge u razvoju i progresiji ove vrste tumora. Materijal i metode: Na uzorku od 28 parafinskih blokova skvamocelularnog karcinoma usne regije, imunohistohemijskom metodom ispitan je ekspresioni status bcl-2 proteina. Mikroskopskom analizom i primenom softvera- Ozaria određen je procenat imunoreaktivnih ćelija u pozitivno obojenim tumorskim regijama. Rezultat: Pozitivnu imunohistohemijsku obojenost pokazalo je 19 od 28 uzoraka (68%) i to: 11 je bilo sa niskim (+), 4 sa srednjim (++) i 4 sa visokim procentom (+++) obojenih ćelija. U grupi pacijenata niskog stadijuma (T2) 50 % uzoraka tumora je pokazivalo ekspresiju bcl-2 proteina dok je u višim stadijumima (T3 i T4) pozitivnih uzoraka bilo 67%. Postojao je trend porasta broja ćelija sa pozitivnom bcl-2 obojenošću kod tumora u višim kliničkim stadijumima, ali ne i povećan nivo ekspresije bcl-2 proteina. Zaključak: Oba parametra, prisustvo bcl-2 obojenosti i procenat ćelija sa bcl-2 imunoekspresijom, mogu predstavljati dopunske prognostičke parametre koji ukazuju na povećan proliferativni potencijal tumora.
Abstract
Aim: The aim of this study was to analyze the presence of the anti-apoptotic protein bcl-2 in oral squamous cell carcinoma and determine its potential role in the development and progression of this type of tumor. Materials and methods: The expression of bcl-2 was determined in 28 paraffin blocks of oral squamous cell carcinoma using the immunohistochemical method. The percentage of the immuno-reactive cells in positively stained tumor regions was determined using the microscopic analysis and Ozaria software. Results: Positive immunohistochemical test was observed in 19 out of 28 samples (68%) as follows: in 11 samples there was a low (+), in four a moderate (++) and in the last four a high percentage (+++) of stained cells. In the group of patients at the low stage of the disease (T2), 50% of tumor samples showed bcl-2 protein expression whereas in the higher stages (T3 and T4) of positively stained samples, this percentage was 67%. There was a trend of an increasing number of cells with positive bcl-2 staining in the tumors of higher clinical stages but not the level of bcl-2 protein expression. Conclusion: Both parameters, the presence of bcl-2 staining and the percentage of cells with bcl-2 immunoexpression, may act as additional prognostic parameters that indicate an increased proliferative tumor potential.
|
|
|
|
Reference
|
|
|
*** (2001) Incidenca i mortalitet od raka u centralnoj Srbiji 2001. Institut za zaštitu zdravlja Srbije Dr Milan Jovanović-Batut, 2005, str. 14-5
|
|
  
|
Attardi, L.D., Lowe, S.W., Brugarolas, J., Jacks, T. (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J, 15(14): 3693-701
|
|
|
Eid, H., Gulyas, M., Geczi, L., Bodrogi, I., Institoris, E., Bak, M. (1998) Expression of bcl-2 in testicular carcinoma: Correlation with tumor progression and MDR1/Pgp. Cancer, 83(2): 331-6
|
|
|
Jameson, J.L. (1998) Principles of molecular medicine. Totowa: Human Press
|
|
1
|
Kuropkat, C., Venkatesan, T.K., Caldarelli, D.D., Panje, W.R., Hutchinson, J., Preisler, H.D., Coon, J.S., Werner, J.A. (2002) Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx. Auris Nasus Larynx, 29(2): 165-74
|
|
|
Lo, M.L., Mignogna, M.D., Pannone, G., Rubini, C., Grassi, R., Nocini, P.F., Ferrari, F., Serpico, R., Favia, G., de Rosa, G., Maiorano, E. (2003) Expression of bcl-2 in oral squamous cell carcinoma: An immunohistochemical study of 90 cases with clinico-pathological correlations. Oncol Rep, 10(2): 285-91
|
|
1
|
Nagler, R.M., Kerner, H., Laufer, D., Ben-Eliezer, S., Minkov, I., Ben-Itzhak, O. (2002) Squamous cell carcinoma of the tongue: The prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett, 186(2): 137-50
|
|
3
|
Oltvai, Z.N., Milliman, C.L., Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74(4): 609-19
|
|
|
Stoll, C., Baretton, G., Ahrens, C., Lohrs, U. (2000) Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. Virchows Arch, 436(2): 102-8
|
|
1
|
Xie, X., Clausen, O.P., de Angelis, P., Boysen, M. (1999) The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer, 86(6): 913-20
|
|
1
|
Yao, L., Iwai, M., Furuta, I. (1999) Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral oncology, Vol. 35, No. 1, pp. 56-62
|
|
|
|
|